antitrypsin

an·ti·tryp·sin

(an'tē-trip'sin),
A substance that inhibits or prevents the action of trypsin.

an·ti·tryp·sin

(an'tē-trip'sin)
A substance that blocks the action of trypsin.

antitrypsin

See ALPHA-ANTITRYPSIN.
References in periodicals archive ?
Further, the analyst believes investor attention should now shift to the company's emerging pipeline, where he sees a "significant opportunity" in the Phase 2-ready alpha-1 antitrypsin deficiency disorder program.
INBRX-101 is a modified recombinant version of human alpha-1 antitrypsin, or AAT, for the treatment of patients with alpha-1 antitrypsin deficiency, or AATD.
Global Banking News-July 2, 2019-Dicerna submits CTA application to Swedish Medical Products Agency for first-in-human Phase 1/2 study of DCR-A1AT for treatment of alpha-1 antitrypsin deficiency-associated liver disease
M2 EQUITYBITES-July 2, 2019-Dicerna submits CTA application to Swedish Medical Products Agency for first-in-human Phase 1/2 study of DCR-A1AT for treatment of alpha-1 antitrypsin deficiency-associated liver disease
M2 PHARMA-July 2, 2019-Dicerna submits CTA application to Swedish Medical Products Agency for first-in-human Phase 1/2 study of DCR-A1AT for treatment of alpha-1 antitrypsin deficiency-associated liver disease
Summary: Looking at the current market trends as well as the promising demand status of the "Alpha 1 Antitrypsin Deficiency Treatment Market", it can be projected that the future years will bring out positive outcomes.
[USPRwire, Fri May 17 2019] Looking at the current market trends as well as the promising demand status of the " Alpha 1 Antitrypsin Deficiency Treatment Market ", it can be projected that the future years will bring out positive outcomes.
Alpha-1 or Alpha-1 Antitrypsin Deficiency is a lack of the protein alpha-1 antitrypsin (AAT) which is produced in the liver.
A set of reagents for the quantitative determination of a1-antitrypsin; To determine antitrypsin, Glycated hemoglobin; To determine hemoglobin, Glycohemoglobin calibrator; To calibrate glycohemoglobin, Glycosylated hemoglobin (type 1) is the norm; For quality control, Glycosylated hemoglobin (type 2) pathology; For quality control
An increased risk for chronic obstructive pulmonary disease (COPD) exists for alpha-1 antitrypsin deficiency (AATD) MZ heterozygotes who have ever smoked [1].
Malanga et al., "Characteristics of Chronic Obstructive Pulmonary Disease (COPD) patients reporting alpha-1 antitrypsin deficiency in the WebMD Lung Health Check Database," Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, vol.
Under the exclusive license the company plans to conduct a Phase II study for the treatment of alpha-1 antitrypsin deficiency, a congenital orphan condition.